CN101044160A - 结核分支杆菌感染的诊断和治疗方法及所用试剂 - Google Patents

结核分支杆菌感染的诊断和治疗方法及所用试剂 Download PDF

Info

Publication number
CN101044160A
CN101044160A CNA2005800359206A CN200580035920A CN101044160A CN 101044160 A CN101044160 A CN 101044160A CN A2005800359206 A CNA2005800359206 A CN A2005800359206A CN 200580035920 A CN200580035920 A CN 200580035920A CN 101044160 A CN101044160 A CN 101044160A
Authority
CN
China
Prior art keywords
bsx
immunogenicity
antibody
peptide
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800359206A
Other languages
English (en)
Chinese (zh)
Inventor
詹姆斯·A·麦金托什
罗伯特·艾伦·科尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteome Systems Ltd
Original Assignee
Proteome Systems Intellectual Property Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteome Systems Intellectual Property Pty Ltd filed Critical Proteome Systems Intellectual Property Pty Ltd
Publication of CN101044160A publication Critical patent/CN101044160A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA2005800359206A 2004-08-19 2005-08-19 结核分支杆菌感染的诊断和治疗方法及所用试剂 Pending CN101044160A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60324304P 2004-08-19 2004-08-19
US60/603,243 2004-08-19

Publications (1)

Publication Number Publication Date
CN101044160A true CN101044160A (zh) 2007-09-26

Family

ID=35907183

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800359206A Pending CN101044160A (zh) 2004-08-19 2005-08-19 结核分支杆菌感染的诊断和治疗方法及所用试剂

Country Status (7)

Country Link
US (1) US20090011426A1 (enExample)
EP (1) EP1794187A4 (enExample)
JP (1) JP2008515388A (enExample)
CN (1) CN101044160A (enExample)
AU (1) AU2005274615A1 (enExample)
CA (1) CA2577597A1 (enExample)
WO (1) WO2006017912A1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102713629A (zh) * 2009-11-20 2012-10-03 俄勒冈健康科学大学 用于检测结核分枝杆菌感染的方法
CN109765379A (zh) * 2018-12-19 2019-05-17 南华大学 结核分枝杆菌蛋白的应用
CN110476065A (zh) * 2017-01-11 2019-11-19 Hav疫苗有限公司 诊断法
CN114874297A (zh) * 2022-04-26 2022-08-09 广东省结核病控制中心 一种结核分枝杆菌蛋白组、其筛选方法及其应用
CN115112897A (zh) * 2021-12-10 2022-09-27 中山大学附属第八医院（深圳福田） 一种用于鉴别抗体检测生物学假阳性的方法
CN117323442A (zh) * 2023-08-30 2024-01-02 广东医科大学 一种巨噬细胞靶向二氧化锰纳米系统的制备方法及其应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012027200A2 (en) * 2010-08-23 2012-03-01 New York University Epitope therapy for infectious diseases
US9404923B2 (en) 2012-02-07 2016-08-02 Intuitive Biosciences, Inc. Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates
ES2758759T3 (es) * 2013-02-14 2020-05-06 Univ Arkansas Composiciones y métodos para potenciar las respuestas inmunitarias a eimeria o limitar la infección por eimeria
GB201315748D0 (en) 2013-09-04 2013-10-16 Imp Innovations Ltd Biological methods and materials for use therein
US9940652B1 (en) * 2014-08-11 2018-04-10 Robert James Cole Restrictively exchanging and controlling vehicular data between communication devices of a private network
CN105181837A (zh) * 2015-08-28 2015-12-23 程永娟 一种结核分枝杆菌检测方法
US11238504B2 (en) * 2018-04-09 2022-02-01 Robert James Cole Systems and methods for restrictively exchanging and controlling product data between communication devices of a private network

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465633B1 (en) * 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
WO2003093307A2 (en) * 2002-04-27 2003-11-13 The Secretary Of State For Environment, Food And Rural Affairs Mycobacterial antigens and uses thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102713629A (zh) * 2009-11-20 2012-10-03 俄勒冈健康科学大学 用于检测结核分枝杆菌感染的方法
CN110476065A (zh) * 2017-01-11 2019-11-19 Hav疫苗有限公司 诊断法
CN110476065B (zh) * 2017-01-11 2024-05-31 Hav疫苗有限公司 诊断法
CN109765379A (zh) * 2018-12-19 2019-05-17 南华大学 结核分枝杆菌蛋白的应用
CN109765379B (zh) * 2018-12-19 2021-11-23 南华大学 结核分枝杆菌蛋白的应用
CN115112897A (zh) * 2021-12-10 2022-09-27 中山大学附属第八医院（深圳福田） 一种用于鉴别抗体检测生物学假阳性的方法
CN114874297A (zh) * 2022-04-26 2022-08-09 广东省结核病控制中心 一种结核分枝杆菌蛋白组、其筛选方法及其应用
CN117323442A (zh) * 2023-08-30 2024-01-02 广东医科大学 一种巨噬细胞靶向二氧化锰纳米系统的制备方法及其应用
CN117323442B (zh) * 2023-08-30 2024-05-03 广东医科大学 一种巨噬细胞靶向二氧化锰纳米系统的制备方法及其应用

Also Published As

Publication number Publication date
EP1794187A1 (en) 2007-06-13
AU2005274615A1 (en) 2006-02-23
US20090011426A1 (en) 2009-01-08
JP2008515388A (ja) 2008-05-15
WO2006017912A1 (en) 2006-02-23
CA2577597A1 (en) 2006-02-23
EP1794187A4 (en) 2008-03-26

Similar Documents

Publication Publication Date Title
CN1902221A (zh) 基于中和表位的生长增强疫苗
CN101044160A (zh) 结核分支杆菌感染的诊断和治疗方法及所用试剂
CN1685236A (zh) N－11端截短的β－淀粉样蛋白的单克隆抗体、组合物、方法和用途
CN1317014A (zh) 检测微生物的抗体
CN1930474A (zh) 变应原的检测方法
CN1118474C (zh) 合成肽及包含其的疫苗
CN1166858A (zh) tagA基因以及检测消化性溃疡和胃癌易感性的方法
CN1125399A (zh) 免疫原性肿瘤蛋白和肽及其使用方法
CN1253470C (zh) 炎症疾病的治疗
CN1249233C (zh) 肺炎衣原体表面蛋白
CN1649626A (zh) 可与触珠蛋白受体配体结合相互作用的分子的用途
CN1628249A (zh) 副结核分枝杆菌感染的诊断和疫苗
CN1694725A (zh) 肽在早期检测分枝杆菌疾病中的应用
CN1735684A (zh) 用于犬和人埃利希病的免疫诊断的p153和p156抗原及其用途
CN1906210A (zh) 表面定位的空肠弯曲杆菌多肽
CN1531653A (zh) 用于鉴定胞内细菌蛋白质的方法
CN1185255C (zh) 检测梅毒密螺旋体的组合物和方法
CN1079400A (zh) 抗肿瘤方法和抗肿瘤剂
CN1149288C (zh) 来自副鸡嗜血杆菌的新多肽及其制备方法
CN1156491C (zh) 经修饰的梅毒螺旋体外膜蛋白质,其免疫检测应用和含有它的试剂盒
CN1966526A (zh) 一种进化免疫球蛋白结合分子、其制备方法及应用
CN1505637A (zh) 克罗恩氏病抗体结合性肽以及克罗恩氏病检查方法
CN1171995C (zh) 一种基于新肽的精神分裂症诊断方法
CN1589278A (zh) lgE结合减少,但T细胞抗原性未减弱的重组变应原
CN1602355A (zh) 与人成纤维细胞生长因子有关的组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: PROTEOME SYSTEMS LIMITED

Free format text: FORMER OWNER: PROTEOME SYSTEMS INTELLECTUAL PROPERTY CO.LTD.

Effective date: 20081114

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20081114

Address after: New South Wales, Australia

Applicant after: Proteome Systems Ltd

Address before: New South Wales, Australia

Applicant before: Proteome Systems Intellectual

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070926